Search Publications

Publications

Pubmed ID Author Year Title

19563188

Xu J

2009

[Effect of electroacupuncture combined with auricular point tapping and pressing on serum insulin and testosterone in the patients of obese women with polycystic ovary syndrome].

19567450

Yildiz BO

2010

Visually scoring hirsutism.

19567514

Victor VM

2009

Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance.

19567518

Vassiliadi DA

2009

Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.

19567524

Hickey M

2009

The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.

19567527

Maliqueo M

2009

Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.

19567528

Ropelato MG

2009

Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents.

19570211

Salvetti NR

2009

An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats.

19570444

Li L

2009

[Effect of anti-M?llerian hormone on P450 aromatase mRNA expression in cultured human luteinized granulose cells].

19571257

Rzepczynska IJ

2009

Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.

19572227

Vrbikova J

2009

Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus.

19573285

Delvigne A

2009

Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS.

19573754

Schuster DP

2009

Changes in physiology with increasing fat mass.

19573758

Hassink SG

2009

Weighing risk: the expert committee's recommendations in practice.

19574176

Rashidi B

2009

The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.

19574280

Sproul K

2009

Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.

19574398

Rice S

2009

Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway.

19576817

Barfield E

2009

The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome.

19577236

Tamimi W

2009

Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome.

19580099

Heng BC

2009

Should patients diagnosed with polycystic ovary syndrome (PCOS) participate in compensated egg sharing in return for subsidized fertility treatment?

19580964

Svendsen PF

2010

The insulin-resistant phenotype of polycystic ovary syndrome.

19583806

Papachroni KK

2010

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue.

19584198

Berga SL

2009

Polycystic ovary syndrome: a model of combinatorial endocrinology?

19584394

Eckmann KR

2009

Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.

19585163

de Sousa G

2010

A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents.

19585444

Kunz J

2009

[18-year-old woman with an ovarian tumour detected by coincidence].

19585478

Grant P

2010

Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial.

19588338

Tang T

2009

WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.

19589515

Sum M

2009

Hypothalamic amenorrhea in young women with underlying polycystic ovary syndrome.

19589517

Hourvitz A

2010

In vitro maturation for patients with repeated in vitro fertilization failure due to oocyte maturation abnormalities.

19589523

Bohler H Jr

2010

Adipose tissue and reproduction in women.

19590426

Yavasoglu I

2009

A novel association between polycystic ovary syndrome and Helicobacter pylori.

19590590

Ciccone MM

2009

Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.

19591017

Deligeoroglou E

2009

The role of genes in the polycystic ovary syndrome: predisposition and mechanisms.

19591981

Battaglia C

2010

Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study.

19591997

Chen MJ

2009

The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.

19593320

Alexander CJ

2009

Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.

19595057

Tao MF

2009

[Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].

19596311

Fan P

2009

Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome.

19602270

Sun J

2009

Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.

19602786

Bilgir O

2009

The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).

19605540

Carmina E

2009

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

19608164

Api M

2009

Could transvaginal, ultrasound-guided ovarian interstitial laser treatment replace laparoscopic ovarian drilling in women with polycystic ovary syndrome resistant to clomiphene citrate?

19609045

Tsutsumi R

2009

GnRH pulsatility, the pituitary response and reproductive dysfunction.

19609106

Priyadarshani A

2009

Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.

19610519

Sultana A

2008

Pituitary gonadotropic hormones in women with oligo/amenorrhoea.

19615041

Li Y

2009

Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo.

19617605

Nardo LG

2009

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.

19621836

Millea PJ

2009

N-acetylcysteine: multiple clinical applications.

19622037

Herken H

2009

The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.

19622210

Wilkes S

2009

Obesity and female fertility: a primary care perspective.

19622617

Cussons AJ

2009

Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.

19622949

Keller J

2009

Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.

19625203

Kowalska I

2009

The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes.

19627713

Roa Barrios M

2009

[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].

19628650

Wehr E

2009

Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.

19629068

Tang T

2009

A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization.

19631369

Villavicencio A

2009

Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

19631445

Vural P

2009

Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.

19632551

Pastore LM

2009

Recruitment strategies for an acupuncture randomized clinical trial of reproductive age women.

19634921

Katsiki N

2009

The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

19635611

Molinaro TA

2009

A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry.

19636212

Sun L

2010

Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.

19639497

G?ven A

2010

Adiponectin and resistin concentrations after glucose load in adolescents with polycystic ovary syndrome.

19639500

Akram T

2010

Association of polycystic ovary syndrome with cardiovascular risk factors.

19639923

Abdel-Gadir A

2009

Coexistence of polycystic ovaries and uterine fibroids and their combined effect on the uterine artery blood flow in relation to age and parity.

19640893

Amer SA

2009

The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy.

19641007

Ryan J

2009

An audit of oral glucose tolerance tests at a large teaching hospital: indications, outcomes and confounding factors.

19642982

Dadgostar H

2009

The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes.

19644950

Lam P

2009

Three-dimensional ultrasound features of the polycystic ovary in Chinese women.

19646674

Shah AA

2009

Early polycystic ovary syndrome as a possible etiology of unexplained premenarcheal ovarian torsion.

19648034

Bekx MT

2010

Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.

19648752

Zheng Q

2009

Family-based association study of the MCF2L2 gene and polycystic ovary syndrome.

19648857

Dara? E

2009

Transvaginal hydrolaparoscopy.

19650762

Pasquali R

2009

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.

19654109

Mueller A

2009

Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.

19655157

Kebapcilar L

2010

Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.

19668673

Orsino A

2005

Clinical features, investigations and management of adolescents with polycystic ovary syndrome.

19671519

Economou F

2009

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.

19672087

Vrbikova J

2009

Impaired glucose metabolism in women with polycystic ovary syndrome.

19676066

Lam P

2009

Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic.

19680559

Feng Y

2009

Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.

19681917

San-Mill?n JL

2010

The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence.

19681918

Sathyapalan T

2010

Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS).

19686401

Percy CA

2009

Nurse-led peer support group: experiences of women with polycystic ovary syndrome.

19686552

DuRant EM

2009

Managing polycystic ovary syndrome: a cognitive behavioral strategy.

19688205

Drohobyczer D

2010

Polycystic ovaries in leprechaunism.

19688613

Lee H

2009

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.

19689407

Reismann P

2009

Pharmacological options for treatment of hyperandrogenic disorders.

19692420

Prodoehl MJ

2009

Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

19692630

Aubuchon M

2009

Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS).

19693712

Petrik JJ

2009

Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.

19693748

Qiu S

2009

Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome.

19697132

Mathur R

2010

Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.

19697191

Leeman L

2009

The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.

19698287

Zurvarra FM

2009

Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.

19700147

Gada D

2009

Luteal-phase clomiphene citrate in PCOS.

19700156

Karkanaki A

2009

Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.

19700609

Franks S

2009

Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized.

19702452

Hirschberg AL

2009

Polycystic ovary syndrome, obesity and reproductive implications.